• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 3. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acids

Comprehensive Analysis of Benzoic acid,3-(4-morpholinylmethyl)-, hydrochloride, hydrate (1:1:1) (CAS No. 857283-67-1)

Benzoic acid,3-(4-morpholinylmethyl)-, hydrochloride, hydrate (1:1:1) (CAS No. 857283-67-1) is a chemically modified derivative of benzoic acid, featuring a morpholine moiety and a hydrochloride salt form. This compound has garnered significant attention in pharmaceutical and biochemical research due to its unique structural properties and potential applications. The presence of the morpholinylmethyl group enhances its solubility and bioavailability, making it a promising candidate for drug development and other specialized applications.

In recent years, the demand for highly soluble organic compounds has surged, particularly in the fields of drug formulation and biochemical assays. Researchers are increasingly focusing on compounds like Benzoic acid,3-(4-morpholinylmethyl)-, hydrochloride, hydrate (1:1:1) due to their ability to improve drug delivery systems. This compound's hydrate form further ensures stability under various environmental conditions, a critical factor for long-term storage and transportation.

The synthesis of Benzoic acid,3-(4-morpholinylmethyl)-, hydrochloride, hydrate (1:1:1) involves a multi-step process, including the introduction of the morpholine group and subsequent salt formation. Advanced techniques such as NMR spectroscopy and mass spectrometry are employed to confirm its purity and structural integrity. These analytical methods are essential for ensuring compliance with pharmaceutical-grade standards, a topic frequently searched by professionals in the field.

One of the most searched questions in the context of this compound is: "What are the applications of morpholine derivatives in medicine?" The answer lies in their versatility. Morpholine derivatives are widely used as intermediates in the synthesis of antibiotics, antifungal agents, and central nervous system (CNS) drugs. The hydrochloride salt form of this compound further enhances its utility by improving its solubility in aqueous solutions, a property highly valued in injectable formulations.

Another trending topic is the role of hydrate forms in pharmaceutical stability. Benzoic acid,3-(4-morpholinylmethyl)-, hydrochloride, hydrate (1:1:1) exemplifies how hydrate forms can mitigate issues like polymorphism and degradation, ensuring consistent performance in final products. This aligns with the growing emphasis on quality-by-design (QbD) principles in drug development, a hot topic in regulatory discussions.

From an industrial perspective, the compound's CAS No. 857283-67-1 serves as a unique identifier, facilitating global trade and regulatory compliance. Companies specializing in fine chemicals and custom synthesis often highlight this compound in their portfolios, catering to the rising demand for high-purity intermediates. Its applications extend beyond pharmaceuticals, finding use in agrochemicals and material science, where its chelating properties are exploited.

In conclusion, Benzoic acid,3-(4-morpholinylmethyl)-, hydrochloride, hydrate (1:1:1) (CAS No. 857283-67-1) represents a versatile and valuable compound in modern chemistry. Its unique structural features, combined with its solubility and stability, make it a focal point for researchers and industries alike. As the scientific community continues to explore its potential, this compound is poised to play a pivotal role in advancing drug delivery systems and other innovative applications.

• 67451-81-4(3-(Morpholinomethyl)benzoic Acid)
• 62642-62-0(4-(Morpholinomethyl)benzoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)